Premier Health Group Inc. (PHGI:CSE; PHGRF:OTCQB; 6PH:FSE) announced in a news release that the first phase of integrating CB2 Insights' clinical decision support (CDS) tool into Premier's Juno electronic medical records (EMR) platform is done and was successful.
The purpose of the CDS tool is to help guide medical professionals through evaluating patients for medical cannabis treatment.
How it works is physicians enter into the system specific information about a patient. Then, based on those parameters, the tool provides guidance. It does so by employing proprietary algorithms that leverage "data from more than 500 clinical research papers and trials as well as the anonymized and aggregate data of more than 450,000 patient encounters that CB2 Insights has managed through its clinical arm," the release noted.
"Our mission is to integrate the best CDS tools directly into our Juno EMR platform that will equip physicians to make enhanced health-related decisions," Premier Health CEO Dr. Essam Hamza said in the release.
In the initial phase, medical cannabis-naïve and -savvy physicians used, tested and provided feedback on the applicability and usability of CB2's tool. Physician support was positive.
Both Premier Health and CB2 plan to have the tool fully integrated, available to the 4,600 primary care physicians and healthcare practitioners who use Juno, by Q3/19.[NLINSERT]
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with Premier Health Group Inc. Please click here for more information. Within the last six months, an affiliate of Streetwise Reports has disseminated information about the private placement of the following companies mentioned in this article: Premium Health Group Inc.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Premier Health Group Inc., a company mentioned in this article.